Skip to main content
logo
Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1400
-0.0099 (-6.60%)
At close: Aug 14, 2026, 4:00 PM EDT
0.132309
-0.0077 (-5.49%)
After-hours: Aug 14, 2026, 7:59 PM EDT

Liminatus Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11-10.21-3.55-4.98-2.93-5.61
Depreciation & Amortization
00---0
Asset Writedown & Restructuring Costs
----0.90.9
Other Operating Activities
7.237.23---1.5
Change in Accounts Payable
-4.35-4.04-0.010.430.090.04
Change in Other Net Operating Assets
-3.7-2.952.111.211.073.01
Operating Cash Flow
-11.82-9.96-1.45-3.35-0.87-0.17
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.01----
Investing Cash Flow
-0.21-0.79-2.85-0.82--

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-4.343.923.419.44-
Total Debt Issued
3.634.343.923.419.44-
Short-Term Debt Repaid
--1.3--3.86-7.03-
Total Debt Repaid
-1.3-1.3--3.86-7.03-
Net Debt Issued (Repaid)
2.333.043.92-0.452.42-
Issuance of Common Stock
14.1410.56--4.2-
Repurchase of Common Stock
-----0.7-
Other Financing Activities
-2.56-2.56----
Financing Cash Flow
13.9111.033.92-0.455.92-

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1.870.28-0.38-4.615.05-0.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.83-9.98-1.45-3.35-0.87-0.17
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.42-0.42-0.08-0.03-0.02-
Levered Free Cash Flow
-7.14-2.92-2.3-0.67-
Unlevered Free Cash Flow
-7.28-2.71-2.19-0.53-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----0.5-
Change in Working Capital
-8.05-6.982.11.641.163.05
SEC Filings: 10-K · 10-Q